KR100515591B1 - 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법 - Google Patents
4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법 Download PDFInfo
- Publication number
- KR100515591B1 KR100515591B1 KR10-2003-0008790A KR20030008790A KR100515591B1 KR 100515591 B1 KR100515591 B1 KR 100515591B1 KR 20030008790 A KR20030008790 A KR 20030008790A KR 100515591 B1 KR100515591 B1 KR 100515591B1
- Authority
- KR
- South Korea
- Prior art keywords
- butoxycarbonyl
- methylene
- amino
- pyrrolidone
- butoxycarbonine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrrole Compounds (AREA)
Abstract
Description
Claims (9)
- a) 이소프로필 알콜 또는 테트라하이드로 퓨란 및 물을 혼합한 용매, 상기 화학식 2로 표시되는 화합물, 및 디-t-부틸 디카보네이트를 혼합한 혼합용액을 제1의 이송펌프를 통하여 마이크로 믹서로 연속적으로 공급하는 단계;b) 강염기 수용액을 제2의 이송펌프를 통하여 마이크로 믹서로 연속적으로 공급하는 단계; 및c) 상기 a)단계의 혼합용액과 b)단계의 강염기 수용액을 마이크로 믹서 내에서 반응시키는 단계를 포함하는 하기 화학식 1로 표시되는 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법:[화학식 1][화학식 2]
- 삭제
- 제1항에 있어서,상기 디-t-부틸 다카보네이트가 상기 화학식 2로 표시되는 화합물 1 당량에 대하여 1.0 내지 1.5 당량으로 포함되는 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법.
- 제1항에 있어서,상기 강염기가 수산화칼륨 또는 수산화나트륨인 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법.
- 제1항에 있어서,상기 강염기 수용액의 농도가 20 내지 50 중량%인 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법.
- 제1항에 있어서,상기 강염기가 상기 화학식 2로 표시되는 화합물 1 당량에 대하여 4 내지 15 당량으로 포함되는 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법.
- 제1항에 있어서,상기 이소프로필 알콜 또는 테트라하이드로 퓨란 및 물을 혼합한 용매, 상기 화학식 2로 표시되는 화합물, 및 디-t-부틸 디카보네이트의 혼합용액에 대하여 강염기 수용액의 부피 유속이 0.5 내지 1.5 배인 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법.
- 제1항에 있어서,상기 c)단계의 반응이 최대 20 ℃의 온도에서 실시되는 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법.
- 제1항에 있어서,상기 c)단계의 반응물을 중화시키는 단계를 추가로 포함하는 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-0008790A KR100515591B1 (ko) | 2003-02-12 | 2003-02-12 | 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-0008790A KR100515591B1 (ko) | 2003-02-12 | 2003-02-12 | 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040072341A KR20040072341A (ko) | 2004-08-18 |
KR100515591B1 true KR100515591B1 (ko) | 2005-09-16 |
Family
ID=37359907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2003-0008790A KR100515591B1 (ko) | 2003-02-12 | 2003-02-12 | 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100515591B1 (ko) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0688772A1 (en) * | 1994-06-16 | 1995-12-27 | LG Chemical Limited | Novel quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation |
JPH08151356A (ja) * | 1994-11-25 | 1996-06-11 | Tokuyama Corp | オキシムカーボネート化合物の製造方法 |
WO1999044991A1 (en) * | 1998-03-04 | 1999-09-10 | Lg Chemical Ltd. | Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one |
JP2002088048A (ja) * | 2000-07-13 | 2002-03-27 | Sumitomo Chem Co Ltd | N−t−ブトキシカルボニルニトロアニリン誘導体の製造法 |
-
2003
- 2003-02-12 KR KR10-2003-0008790A patent/KR100515591B1/ko active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0688772A1 (en) * | 1994-06-16 | 1995-12-27 | LG Chemical Limited | Novel quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation |
JPH08151356A (ja) * | 1994-11-25 | 1996-06-11 | Tokuyama Corp | オキシムカーボネート化合物の製造方法 |
WO1999044991A1 (en) * | 1998-03-04 | 1999-09-10 | Lg Chemical Ltd. | Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one |
JP2002088048A (ja) * | 2000-07-13 | 2002-03-27 | Sumitomo Chem Co Ltd | N−t−ブトキシカルボニルニトロアニリン誘導体の製造法 |
Also Published As
Publication number | Publication date |
---|---|
KR20040072341A (ko) | 2004-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102040494A (zh) | 对氟苯甲醛的制备方法 | |
CN105949118B (zh) | 一种2-芳基喹啉衍生物的制备方法 | |
CN113582880B (zh) | 一种(3-氨基二环[1.1.1]戊烷-1-基)氨基甲酸叔丁酯的制备方法 | |
KR100515591B1 (ko) | 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법 | |
CN102548957A (zh) | 制备苏-3-(3,4-二羟基苯基)-l-丝氨酸的方法 | |
CN111848517A (zh) | 一种依达拉奉的制备方法 | |
CN109232427A (zh) | 一种依达拉奉的制备方法 | |
US7081548B2 (en) | Process for preparing 3-chloro-5-nitrotoluene | |
CN112079772A (zh) | 一种4-三氟甲基烟酸中氨化反应的方法 | |
CN101155795A (zh) | 生产经取代的噻吩磺酰基异氰酸酯的方法 | |
CN113121518B (zh) | 一种特地唑胺杂质的制备方法 | |
CN110105222A (zh) | 一种4-氨基茚满类化合物的新型制备方法 | |
JPH04149160A (ja) | 1―アミノ―4―アルコキシベンゼン類の製造方法 | |
JP4202148B2 (ja) | 2−アミノトロポンの製造方法 | |
KR100701743B1 (ko) | 밤부테롤의 신규한 제조 방법 | |
KR102662895B1 (ko) | 고순도 트로픽아미드의 제조방법 | |
CN110256387B (zh) | 一种医药中间体的制备方法 | |
CN117304186A (zh) | 一种非奈利酮的制备方法、非奈利酮中间体及其制备方法 | |
KR100234626B1 (ko) | 2-(2,6-디클로로페닐)아미노)페닐아세톡시아세트산의제조방법 | |
CN110204490B (zh) | 一种二取代4-氯喹啉-3-甲腈衍生物及伯舒替尼的制备方法 | |
CN107879955B (zh) | 一种格列本脲的合成方法 | |
KR100368896B1 (ko) | 6-아미노메틸-5H-디벤즈[b,e]아제핀의 제조방법 | |
CN112759552A (zh) | 司美替尼的合成方法 | |
CN115594688A (zh) | 瑞卢戈利中间体的制备方法 | |
JP3959178B2 (ja) | ヒドラジン誘導体の製造方法、その中間体および中間体の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130830 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140716 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150716 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160817 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170718 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180619 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20190625 Year of fee payment: 15 |